Listing on Guidance for Family Choice Pharmacy of Lee's Pharm signature products, Ferplex and Yallaferon

Health awareness is enhanced among the community from COVID-19 pandemic that has lasted for nearly two years. It is common to prepare for emergencies by stocking essential medicines at home. Hong Kong, December 23, 2021, the '2020-2021 Top Brand List of Family Choice Pharmacy in China', jointly organized by familydoctor.com.cn and Sinomonitor, was officially announced through online platform. Two of the signature products from Lee's Pharmaceutical Holdings Limited ('Lee's Pharm' or 'the Group') are granted admission into the guidance list. The in- licensed product Ferplex and the in-house proprietary product Yallaferon, are listed in the 'Health Supplement Category' and 'Gynecological Category' respectively.

Ferplex, lron Proteinsuccinylate Oral Solution is indicated for absolute and relative iron deficiency anemia, recessive or dominant iron deficiency anemia caused by inadequate iron intake or absorption disorder, acute or chronic bleeding and infection.

Yallaferon, Interferon ?2b Gel is indicated for condyloma acuminatum, herpes zoster, herpes labiais, herpes genitalis, cervical HPV infection and cervical ectropion. Yallaferon does not need to be refrigerated and is convenient to carry, which can be applied to the nostrils, mouth, or skin surface to prevent viral infections. In the early 2020, it has become one of the critical anti-epidemic strategic materials in China.

This guidance list is voluntarily declared by pharmaceutical companies, and has undergone multiple screenings including preliminary screening, public online voting, data weighting and experts' review. A total of 109 pharmaceutical products with 28 categories are announced. It is aimed to provide public with guidance on family choice medicine, and to drives the development of the pharmaceutical industry as well. Over the past two decades, Lee's Pharm is devoted to developing innovative products to fight diseases and improve health and quality of human life.

Contact:

Kahlen Cheng

T: [phone]

E: [e-mail]

(C) 2021 Electronic News Publishing, source ENP Newswire